RAMBALDI ALESSANDRO
Pubblicazioni
Lussana, F., Magnani, C., Galimberti, S., Gritti, G., Gaipa, G., Belotti, D., et al. (2025). Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01260-6]. Dettaglio
Pisani, I., Melita, G., de Souza, P., Galimberti, S., Savino, A., Sarno, J., et al. (2025). Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. JOURNAL OF TRANSLATIONAL MEDICINE, 23(1) [10.1186/s12967-025-06416-3]. Dettaglio
Zaninelli, S., Meli, C., Borleri, G., Quaroni, M., Pavoni, C., Gaipa, G., et al. (2024). Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining. CYTOMETRY. PART A, 105(2 (February 2024)), 112-123 [10.1002/cyto.a.24796]. Dettaglio
Castelli, M., Mico, M., Grassi, A., Algarotti, A., Lussana, F., Finazzi, M., et al. (2024). Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience. BONE MARROW TRANSPLANTATION, 59(8), 1161-1168 [10.1038/s41409-024-02305-3]. Dettaglio
Zaninelli, S., Panna, S., Tettamanti, S., Melita, G., Doni, A., D'Autilia, F., et al. (2024). Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. ANTIBODIES, 13(3) [10.3390/antib13030071]. Dettaglio